Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, MiRNA-based therapy for Chronic Myelogenous Leukemia (CML): MiRNA-373 eradicates CML leukemia stem cells via activation of p53, 11/October/2014, 05.07 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that tumor suppressor MiRNA-373, by decreasing the expression of its target gene, it may increase the expression of guardian of the genome p53; and decrease the expression of immortality gene telomerase. Given that p53 is the most mutated tumor suppressor gene in human cancer, pharmacological formulations encompassing “MiRNA-373 or its activators may be used to eliminate CML leukemia stem cells.

Spread the love